Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Drug-Drug Interactions of AG2203L and AG2203E in Healthy Adult Participants
NCT07797621Phase 1Completed
- Sponsor
- Ahn-Gook Pharmaceutical Co., Ltd.
- Start
- Mar 2025
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of AG2203L and AG2203E in acute bronchitis (6 arms), sponsored by Ahn-Gook Pharmaceutical Co., Ltd. Primary endpoints: Area Under the Concentration-Time Curve at Steady State and Maximum Observed Plasma Concentration at Steady State. Started Mar 2025; status: completed.
02
Drugs
AG2203LAG2203E
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT07797621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07797621.